INDEX 849
psoriasiform-lichenoid dermatosis, 434
see alsoEnglish springer spaniel
squames (exfoliating corneocytes),7, 9
squamous cell carcinoma (SCC), cutaneous
client education/prognosis, 679
clinical features, 576,585–587,675–676,681–683
diagnostics, 577, 677–678
differential diagnosis, 577, 677
etiology/pathophysiology, 672
premalignant lesions, 575
signalment/history, 673, 674–675
solar induced, 574, 672
therapeutics, 678–679
squamous cell carcinomain situ seeBowen’s disease
squeeze tape impressions, 44–45
stable flies(Stomoxys calcitrans), 240
Staffordshire bull terrier, 744
demodicosis, 297
leproid granuloma, 512
mast cell tumors, 495
tail biting or chasing, 228
see alsoAmerican Staffordshire terrier
standard poodle, 741
sebaceous adenitis,82, 98,434,449–450,648,651,
652
trichoepithelioma, 674
standard schnauzer, 744
stanozolol, 810
Staphage lysate, 217
staphoid A, 217
staph vaccine therapy, 217
staphylococcal scalded skin syndrome, 144
staphylococci, 143, 213
bacterial overgrowth syndrome, 215
biofilms, 144
coagulase-negative and -positive, 143
folliculitisseefolliculitis, bacterial
methicillin resistance, 143–144
relationship withMalassezia, 484
virulence factors, 144–145
Staphylococcus aureus, 213
methicillin resistantseemethicillin-resistant
Staphylococcus aureus
zoonotic potential, 146
Staphylococcus pseudintermedius, 143, 144, 213
methicillin resistantseemethicillin-resistant
Staphylococcus pseudintermedius
resident vs transient strains, 212
zoonotic potential, 146
Staphylococcus schleiferi, 143, 213
methicillin resistantseemethicillin-resistant
Staphylococcus schleiferi
zoonotic potential, 146
sterile idiopathic interdigital granuloma, 589, 598
sterile (idiopathic) nodular panniculitis (SNP), 65,
126,563, 564, 565, 566
Stevens–Johnson syndrome (SJS), 272–275
sticktight flea, 239, 248
stratum basale, 5
stratum corneum, 3, 4,4, 5
stratum granulosum, 5
stratum spinosum, 5
streptokinase, 144
streptolysin, 144
Sublimazeseefentanyl
sucralfate, 151, 499, 810
Sulcrateseesucralfate
sulfadiazine, 811
see alsotrimethoprim + sulfadiazine
sulfasalazine (sulfapyridine + mesalamine), 702, 811
sulfonamides
adverse reactions, 272
potentiated, 151, 219
sulfur/salicylic acid washes, 437
superantigens, 145, 215
superficial necrolytic dermatosis (SND), 665–668
clinical features, 62, 64, 619,630–631,666,669–670
diagnostics, 622, 667, 671
differential diagnosis, 621, 666–667
etiology/pathophysiology, 616, 665
footpads,104, 135,592, 608
signalment/history, 617, 666
therapeutics, 624, 668
supracaudal glandseetail gland
Supraxseecefixime
symptom checker, 59–69,69–141
Synthroidseelevothyroxine
systemic lupus erythematosus (SLE), 63, 112
clinical features, 470,478–479, 705
course and prognosis, 472
diagnostics, 471
nasal planum, 67
pigmentation abnormalities, 65
signalment/history, 469
therapeutics, 471–472T 3 (triiodothyronine), 416, 420
T 4 (tetraiodothyronine), 416
free, 420
total, 419–420, 422
Tabanusspp. (horseflies), 240
tacrolimus ointment
for anal furunculosis/perianal fistula, 164
for cutaneous adverse drug reactions, 275
for lupus erythematosus, 472
for pemphigus complex, 196
Tagametseecimetidine
tail biting/chasing
clinical features, 229–230,237–238
diagnostics, 232
differential diagnosis, 230–231
signalment/history, 228
tail gland
alopecia, 60, 81
hyperplasia, 339, 350
Tapazoleseemethimazole